Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 2 Antimicrobial susceptibility of study isolates

From: In vitro susceptibility of clinical Clostridioides difficile isolates in Israel to metronidazole, vancomycin, fidaxomicin, ridinilazole and ibezapolstat,

Antimicrobial agent

MIC Range (mg/L)

MIC50

(mg/L)

MIC90

(mg/L)

Geometric MIC mean (mg/L)

% Resistance

Metronidazole

0.016-256

0.19

0.38

6

2.2

Vancomycin

0.064-256

0.5

0.75

2.5

1.9

Fidaxomicin

0.03-16

0.25

0.5

0.81

7.35

Ridinilazole

0.06–0.5

0.25

0.5

0.32

N.A.

Ibezapolstat

0.5-8

4

4

3.1

N.A.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us